Alpha Crest Capital Management LLC Sage Therapeutics, Inc. Transaction History

Alpha Crest Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$40.26 - $57.37 $232,380 - $331,139	-5,772 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$54.88 - $79.29 $144,334 - $208,532	2,630 Added 83.7%	5,772 $328,000
Q1 2021 May 13, 2021	BUY	$70.65 - $96.76 $221,982 - $304,019	3,142 New	3,142 $235,000
Q4 2019 Feb 12, 2020	SELL	$60.18 - $154.77 $108,324 - $278,586	-1,800 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $252,522 - $341,928	1,800 New	1,800 $253,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.